AstraZeneca shares surged by 8 per cent at one stage amid frenzied speculation that US rival Pfizer was preparing a mega-bid. Photograph: Chris Ratcliffe/Bloomberg

A flurry of deals and speculation of more to come has set the pharmaceuticals sector alight, sending shares in some of the UK’s biggest drugs g(...)

Mathew Martoma, a former SAC Capital Advisors fund manager exits federal court with his wife Rosemary Martoma,  in New York, today after being  found guilty in the most lucrative insider trading scheme ever. Photographer: Louis Lanzano/Bloomberg

Mathew Martoma, a former portfolio manager at billionaire Steven A. Cohen’s SAC Capital Advisors hedge fund, was found guilty tonight of engaging in w(...)

Mathew Martoma, a former portfolio manager with SAC Capital Advisors LP, “sought out an illegal edge”, prosecutors claimed, when he contacted two doctors taking part in a clinical trial for an experimental drug to treat Alzheimer’s disease. Photographer: Peter Foley/Bloomberg

Mathew Martoma “corrupted” medical doctors to gain an early look at confidential drug trial results that enabled hedge fund SAC Capital to make more t(...)

Mathew Martoma, a former portfolio manager with SAC Capital Advisors LP, arrives at federal court in New York, U.S., on Tuesday, Jan. 7, 2014. Photographer: Peter Foley/Bloomberg

Mathew Martoma may have the one thing prosecutors have been unable to find in their probe of SAC Capital Advisors: a direct link between founder Steve(...)

Mathew Martoma: a former SAC portfolio manager, is charged with using confidential information provided by two doctors involved in clinical trials to trade in drug firms Elan and Wyeth, which is now owned by Pfizer. Photograph: Reuters

A trial starting this week over what US prosecutors call the most lucrative insider trading scheme ever will likely delve into the trading activity of(...)

Unite trade union has pledged to immediately engage with MSD management and proactively help the IDA to find a buyer for the facility. Photograph: Brian Lawless/PA Wire

The Christmas tree was up in the MSD pharmaceutical plant in Swords yesterday but there was little cheer among staff who were told that it is to close(...)

Dr Paul Duffy,  vice president of Pfizer, which has announced a major investment in its Irish plants Photograph:  Daragh McSweeney/Provision

US drug giant Pfizer will invest $130 million upgrading two of its Irish plants to accommodate work on new drugs coming through its pipeline.The compa(...)

The Elan Corporation pharmaceutical plant in Athlone. A US federal judge has been asked to dismiss two insider trading charges tied to sales of Elan’s US depositary receipts. Photograph: John Cogill/Bloomberg News

Former SAC Capital Advisors portfolio manager Mathew Martoma has urged a federal judge to dismiss two insider trading charges tied to his firm’s sales(...)

The high price of infant formula and drugs have become politically sensitive issues for Beijing

Beijing’s investigation of foreign companies for alleged price fixing has extended to the pharmaceuticals industry, with the National Development and (...)

Viagra was the company’s sixth best-selling drug last year, pulling in income of $2.05 billion, up 4 per cent on 2011.

Pfizer’s little blue pill, Viagra, loses patent protection in Ireland and Britain today. It is just the latest blockbuster drug to fall off the patent(...)